Delivery Order N0018924DZ018-W81K0426FA234

The Department of the Army issued a delivery order to Microgenics Corporation on December 10, 2025, for MDMA/MDA reagent kits with a ceiling value of $12,518.40. The order is firm fixed price and matures January 1, 2026. Place of performance is Fort Meade, MD. This delivery order is issued under a parent IDV for MDMA/MDA reagent kits valued at $1,154,822.40. Microgenics Corporation, through its Clinical Diagnostics Division, manufactures immunoassay reagent test kits for clinical toxicology...

The Department of the Army issued a $25,036.80 delivery order to Microgenics Corporation on February 28, 2025, for MDMA clinical diagnostic supplies with an ultimate completion date of August 15, 2025. Place of performance is Fort Meade, Maryland. The order is firm fixed price with no set-aside. Microgenics Corporation, a clinical diagnostics division specializing in immunoassay reagent test kits for substance detection and medical screening, serves as the awardee under a parent indefinite...

The U.S. Navy Bureau of Medicine and Surgery awarded a delivery order valued at $12,518.40 to Microgenics Corporation on August 1, 2025, for MDMA/MDA reagent kits (Part Number 10024631PSC). This firm fixed-price delivery order, with an ultimate completion date of August 12, 2025, will be performed in Fremont, California, and does not utilize a set-aside designation. Microgenics Corporation, a clinical diagnostics division subsidiary of Thermo Electron Corporation, specializes in manufacturing...

The Defense Health Agency issued a delivery order to Microgenics Corporation on June 1, 2025, with a ceiling value of $16,269.60 for DRI opiate reagent kits, completing August 3, 2026. This is a firm fixed-price delivery order against a parent indefinite delivery contract. Place of performance is Fort Meade, MD. Microgenics Corporation, operating through its Clinical Diagnostics Division, supplies immunoassay reagent test kits for substance detection and medical screening to military and...

This is a delivery order award to Microgenics Corporation, a subsidiary of Thermo Electron Corporation, for the supply of MDMA/MDA reagent kits. The award, valued at $12,518.40, was made by the Navy Bureau of Medicine and Surgery, a component of the Department of Defense. This delivery order is issued against an existing $1.15 million single-award indefinite delivery contract held by Microgenics for the provision of these specialized diagnostic reagents. The MDMA/MDA reagent kits are used to...

This is a firm fixed-price delivery order contract awarded by the Navy Bureau of Medicine and Surgery, a defense agency, to Microgenics Corporation for the supply of MDMA/MDA reagent kits. The $12,518.40 contract has an ultimate completion date of December 18, 2024. Microgenics, a clinical diagnostics division of Thermo Electron Corporation, is an established supplier of immunoassay reagent test kits and other laboratory supplies to support the Department of Defense Drug Demand Reduction...

The Department of the Navy Bureau of Medicine and Surgery awarded a $12,039 firm fixed price delivery order to Microgenics Corporation for DRI-ECSTASY PLUS MDMA/MDA REAGENT. Microgenics Corporation, a division of Thermo Electron Corporation, will deliver the requested MDMA/MDA reagents under the contract to their place of performance in Fremont, California by July 23, 2021. No set-aside designation was applied to this solicitation for MDMA/MDA test reagents, which will support the Department...

The Department of the Navy Bureau of Medicine and Surgery awarded a $12,039 firm fixed price delivery order to Microgenics Corporation for DRI-ECSTASY PLUS MDMA/MDA REAGENT. Microgenics, a division of Thermo Electron Corporation, will deliver the requested drug identification and screening reagents to the place of performance in Fremont, California by the November 18, 2021 completion date. No set-aside designation was applied to this solicitation for MDMA/MDA reagents under the base IDIQ...

The Department of the Navy Bureau of Medicine and Surgery awarded a $6,420.80 firm fixed price delivery order contract to Microgenics Corporation for DRI-ECSTASY PLUS MDMA/MDA reagent. As the clinical diagnostics division of Thermo Electron Corporation, Microgenics will deliver the requested reagent products to the place of performance in Fremont, California by the completion date of March 24, 2023. No set-aside designation was used for this award issued on March 17, 2023 in support of the...

The Department of the Navy Bureau of Medicine and Surgery awarded a $5,016.25 firm fixed price delivery order contract to Microgenics Corporation for DRI-ECSTASY PLUS 500ML MDMA/MDA REAGENT. As the clinical diagnostics division of Thermo Electron Corporation, Microgenics will deliver the requested MDMA/MDA reagent product to a location in Fremont, California by the completion date of June 3, 2021. No set-aside designation was used for this award to the prime contractor Microgenics. The Bureau of...